Cancer Drug May Help Patients With Heart-lung Disease

Tuesday, May 20, 2008 - 21:28 in Health & Medicine

A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension. In the first human trial of sorafenib as a treatment for pulmonary hypertension, 8 out of the first 9 patients increased their ability to exercise. Six out of 9 had improved right ventricular ejection fraction. Four had a significant decrease in pulmonary artery pressures.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net